MARSHALL FIFE: Open Payments
NPI 1013426717 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,113 in 60 payments from 13 companies in 2025. Trend: 2023 $1,772 · 2024 $881 · 2025 $1,113
Food & beverage: $1,113
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 10 | $214 |
| E.R. Squibb & Sons, L.L.C. | 7 | $171 |
| ABBVIE INC. | 15 | $144 |
| Alkermes, Inc. | 6 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $113 |
| Axsome Therapeutics, Inc. | 4 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| Noven Therapeutics, LLC | 3 | $55 |
| Supernus Pharmaceuticals, Inc. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
Products named: COBENFY, FANAPT, VRAYLAR, TRINTELLIX, Auvelity, CAPLYTA, HETLIOZ, LYBALVI.
Industry payments across TN — which companies pay providers there.
